Clinical Trials Browser

HER-2 Negative Breast Cancer

Urinary Bladder Neoplasms

Peritoneal Neoplasms

Breast Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

Locally Advanced Rectal Cancer With Liver Metastases

Neoplasms, Neuroendocrine Tumors

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Rectal Neoplasms

Triple Negative Breast Neoplasms

Stomach Neoplasms

Acrocephalosyndactylia

Primary/Secondary Prevention

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Non-Small-Cell Lung

Neoplasms, Germ Cell and Embryonal

Brain Neoplasms

Carcinoma, Non-Small-Cell Lung

Unresectable Non-small Cell Lung Cancer

Neoplasms, Ovarian Neoplasms

HR+/HER2- Breast Cancer

Pathologic Complete Response, Breast Neoplasms

Unresectable Pancreatic Cancer

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Papillomavirus Infections

Uterine Cervical Neoplasms, Renal Insufficiency

Colorectal Neoplasms

Pathologic Complete Response, Breast Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms

Gastric/Gastroesophageal Junction Adenocarcinoma

Cholangiocarcinoma

Rectal Neoplasms

Pathologic Complete Response, Breast Neoplasms

Turcot syndrome, Endometrial Neoplasms

Platelet Recovery After Umbilical Cord Blood Transplantation

HER2 Low Breast Carcinoma

Alzheimer Disease, Lymphoma, Follicular, Cognitive Dysfunction

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Advanced Breast Cancer

Carcinoma, Hepatocellular

Clinical Trials

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

IMGeS

PrimPIPAC

Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases

SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer

Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

TENET

NEOPRIME

QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer

NOGA

SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC

Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC

Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions

NCCH2006/MK010 Trial (FORTUNE Trial)

Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN

Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma

KOV-02S

NICE-CC

TARGET-01

LART

DACT-GCT

Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

OC-POP-PT

Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Dulastin

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

AHTCRR-1

Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC

ACCESS-I

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer

Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients

A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG

Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma

Adebrelimab Injection (PD-L1) Combined With Short Course Radiotherapy and Chemotherapy for Neoadjuvant Therapy of Locally Advanced Rectal Cancer

Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer

SATELLITE

Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT

A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer

FEAD

Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial

Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab